Celldex Therapeutics CLDX
NASDAQ CLDX
$32.37 -0.04 (-0.12%)
As of: Oct 1, 2026 · 2:30 PM EDT

Celldex Therapeutics (CLDX) Long-Term Debt Repayments (2010 - 2013)

Updated

Celldex Therapeutics (CLDX) reported Long-Term Debt Repayments of $2.96 million for FY2020.

Analysis

Celldex Therapeutics (CLDX) Long-Term Debt Repayments (2010 - 2013) Analysis & Trends

Dating back to FY2009, Celldex Therapeutics' Long-Term Debt Repayments record includes 6 years.

  • The FY2020 figure ranks as the highest annual Long-Term Debt Repayments since FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Celldex Therapeutics 2.54 Bn 2.54 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 9.71 Mn
Mar 31, 2013 1.32 Mn
Dec 31, 2012 1.33 Mn
Sep 30, 2012 2.62 Mn
Jun 30, 2012 14,000.00
Mar 31, 2012 15,000.00
Mar 31, 2011 12.50 Mn
Dec 31, 2010 52,000.00
Sep 30, 2010 51,000.00
API Access

Celldex Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CLDX&period=max&api_key=YOUR_API_KEY